InTouch Newsletter Issue 7
Congresses and Events
PCR London Valves Webcast:
The ACURATE neo™ TAVI System, simplifying TAVI procedures
A webcast from PCR London Valves in which some experts discuss the latest clinical evidence, the intuitive implantation procedure and recognize how ACURATE neo™ compares to a balloon-expandable valve.
Short DAPT Trial with SYNERGY™ BP Stent: Superior outcomes in Elderly Patients
SYNERGY™ showed superior outcomes compared to a bare metal stent in the treatment of elderly patients with short DAPT duration (1 month in stable patients and 6 months in patients with ACS). This is the result of the SENIOR Trial presented at TCT 2017, in which SYNERGY™ reported 0% def/prob ST after early DAPT discontinuation.
Watch Prof. O. Varenne discuss the outcomes of the trial.
InCathLab Live Case: How should I treat complex anatomy lesions and manage complications?
St. Gallen, Switzerland
An interactive discussion focused on four live cases performed by Dr. Daniel Weilenmann from St. Gallen (Switzerland).
Watch the video and improve your knowledge on complex anatomy treatment with ROTABLATOR™ and CTO techniques.
GUIDEZILLA™ II: The next generation Guide Extension Catheter
GUIDEZILLA™ II is the next generation guide extension catheter, whose design features have been optimized to make it the best tool for complex PCI cases. It takes durability, powerful reach and confidence to new places, from routine cases to complex anatomies. GUIDEZILLA™ II takes durability, powerful reach and confidence to new places, from routine cases to complex anatomies.
InCathLab Live Case: Discussion around complex PCI. How to deal with complications?
Three complex coronary interventions performed by Dr A. Serra, Dr L. Azzalini and Dr D. Weilenmann, who discuss about strategies and techniques for a good PCI outcome and device selection. Watch Dr Serra presenting a calcified distal right coronary bifurcation treated with ROTABLATOR™ to facilitate coronary stenting.
WATCHMAN™ LAAC Device: New PREVAIL 5 Year Data from TCT and 5 Year Meta-Analysis results published in JACC
The 5 year combined data from PROTECT-AF and PREVAIL confirmed the safety and efficacy of WATCHMAN™ LAAC Device in stroke prevention. It offered comparable stroke risk reduction as well as statistically significant reductions in disabling and fatal stroke* (-55%), non-procedure related major bleeding (-52%), and mortality (-41% CV death) vs. warfarin after 5 years of follow-up¹.
FAME 2 Trial 3-year Outcome and
cost-effectiveness of FFR
Compared with best medical therapy alone, performing PCI in patients with stable CAD and at least one coronary lesion with an abnormal FFR leads to improved clinical outcome, less angina, and improved quality of life at similar cost over three years of follow-up. See the 3-year data from the FAME 2 Trial presented at TCT 2017.
SYNERGY™ BP Stent: outstanding results from the Swedish SCAAR Registry
The SCAAR Registry published data that further solidifies SYNERGY™ BP Stent as one of the best stents in the market today. In the study, SYNERGY™ demonstrated the numerically lowest stent thrombosis rates at 1-year compared to all other newer generation stents combined, despite being used in statistically more complex patients2.
* Two strokes in PREVAIL are excluded because the baseline MRS score was unavailable
1. Reddy VY, 5-Year Outcomes After Left Atrial Appendage Closure From the PREVAIL and PROTECT AF Trials. DOI: 10.1016/j.jacc.2017.10.021
2. Sarno, G., et al. Cathet. Cardiovasc. Intervent.. doi:10.1002/ccd.27030